Vokes E - Search Results

1

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.

Redman MW, Papadimitrakopoulou VA, Minichiello K, Hirsch FR, Mack PC, Schwartz LH, Vokes E, Ramalingam S, Leighl N, Bradley J, Miao J, Moon J, Highleyman L, Miwa C, LeBlanc ML, Malik S, Miller VA, Sigal EV, Adam S, Wholley D, Sigman C, Smolich B, Blanke CD, Kelly K, Gandara DR, Herbst RS. Redman MW, et al. Among authors: vokes e. Lancet Oncol. 2020 Dec;21(12):1589-1601. doi: 10.1016/S1470-2045(20)30475-7. Epub 2020 Oct 27. Lancet Oncol. 2020. PMID: 33125909 Free PMC article. Clinical Trial.

2

The evolving role of systemic therapy in carcinoma of the lung.

Haraf DJ, Devine S, Ihde DC, Vokes EE. Haraf DJ, et al. Among authors: vokes ee. Semin Oncol. 1992 Aug;19(4 Suppl 11):72-87. Semin Oncol. 1992. PMID: 1324527 Review.

3

Investigation chemotherapy in multimodality therapy of non-small cell lung cancer.

Vokes EE. Vokes EE. Front Radiat Ther Oncol. 1992;26:64-71. Front Radiat Ther Oncol. 1992. PMID: 1324877 Review. No abstract available.

4

Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B.

Vokes EE, Lyss AP, Herndon JE 2nd, Cooper B, Perry MC, Vinciguerra V, Mason-Coughlin K, Green MR. Vokes EE, et al. Ann Oncol. 1992 Nov;3(9):727-32. doi: 10.1093/oxfordjournals.annonc.a058328. Ann Oncol. 1992. PMID: 1333267 Free article. Clinical Trial.

5

Chemotherapy for stage IV non-small cell lung cancer.

Bitran JD, Vokes EE. Bitran JD, et al. Among authors: vokes ee. Hematol Oncol Clin North Am. 1990 Dec;4(6):1159-68. Hematol Oncol Clin North Am. 1990. PMID: 1704879 Review.

6

Sequential combined modality therapy for stage III non-small cell lung cancer.

Vokes EE. Vokes EE. Hematol Oncol Clin North Am. 1990 Dec;4(6):1133-42. Hematol Oncol Clin North Am. 1990. PMID: 1962780 Review.

7

Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.

Vokes EE, Mick R, Lester EP, Panje WR, Weichselbaum RR. Vokes EE, et al. J Clin Oncol. 1991 Aug;9(8):1376-84. doi: 10.1200/JCO.1991.9.8.1376. J Clin Oncol. 1991. PMID: 2072141

8

Role of systemic therapy in advanced non-small-cell lung cancer.

Vokes EE, Vijayakumar S, Bitran JD, Hoffman PC, Golomb HM. Vokes EE, et al. Am J Med. 1990 Dec;89(6):777-86. doi: 10.1016/0002-9343(90)90221-x. Am J Med. 1990. PMID: 2174646 Review.

9

Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.

Vokes EE, Bitran JD, Hoffman PC, Ferguson MK, Weichselbaum RR, Golomb HM. Vokes EE, et al. Chest. 1989 Jul;96(1):110-3. doi: 10.1378/chest.96.1.110. Chest. 1989. PMID: 2544349

10

Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.

Vokes EE, Rosenberg RK, Jahanzeb M, Craig JB, Gralla RJ, Belani CP, Jones SE, Bigley JW, Hohneker JA. Vokes EE, et al. J Clin Oncol. 1995 Mar;13(3):637-44. doi: 10.1200/JCO.1995.13.3.637. J Clin Oncol. 1995. PMID: 7533824 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

632 results

Search Page